Category Archives: Weekly news mash-up

The weekly healthcare news roundup

Health care in America costs more than in other industrialized nation and we aren’t even getting the world’s best care for our dollars, according to a new study. The United States spent $7,960 per capita on health care in 2009, the most of 13 industrialized nations in the Organization for Economic Cooperation and Development. Continue reading

A wrap of this weeks healthcare news

U.S. health care reform* is on the Supreme Court’s operating table. It’s going to be a long, painful procedure, multiple amputations are likely, and the patient’s survival is uncertain. Whatever the outcome, however, the economic pressure that health care costs put on employers and individuals will continue to mount, and they will seek better value aggressively. This drives us towards an era of “customer-driven” healthcare. Continue reading

Headlines in healthcare this week

A study released on Thursday shows that one in four working-age Americans went without insurance at some point in 2011, often as a result of unemployment and other job changes. The study by the Commonwealth Fund polled 2,100 people aged 19 to 64 and found that 26 percent of non-elderly adults went without insurance — a percentage that researchers said equals about 48 million people when measured against U.S. Census data. Continue reading

Friday news story summaries on healthcare

The number of prescriptions issued to patients declined by 1.1 percent compared with 2010, and visits to the doctor fell by 4.7 percent, the report said. Visits to the emergency room, by contrast, increased by 7.4 percent in 2011, an increase that the report’s authors said was linked to the loss of health insurance resulting from long-term unemployment. Continue reading

Wrap up of the weeks healthcare stories

Half of all cancers could be prevented if people just adopted healthier behaviors, US scientists argued on Wednesday.  Smoking is blamed for a third of all US cancer cases and being overweight leads to another 20 percent of the deadly burden that costs the United States some $226 billion per year in health care expenses and lost productivity. Continue reading

Summary of healthcare headlines this week

Between 2006 and 2009, U.S. sales of Viagra as reported by Pfizer to the S.E.C. increased from $796 million to $962 million, a 21% increase. During the same time period, IMS Health says the number of U.S. prescriptions for Viagra fell from 11.2 million to 9.9 million, a 13% decrease. Sales increased while usage decreased, because Pfizer increased the price.   Price increases and overseas  sales masked the decline.  Price increases account for48% of US pharma sales growth since 1980. Continue reading

The top headlines in healthcare news this week

British experts at the world’s biggest artificial joint registry said doctors should stop using metal-on-metal hip replacements, citing an analysis showing they have to be fixed or replaced more often than other implants. Continue reading

A wrap up of this weeks healthcare news

Two more patients in a 10-patient segment of a mid-stage trial testing Gilead Sciences Inc’s experimental hepatitis C drug GS-7977 had the virus return within four weeks of treatment, researchers said on Tuesday. The company, which recently paid nearly $11 billion to acquire the drug and its developer, Pharmasset, said last month that six out of 10 patients with a prior “null response” to standard hepatitis C therapy saw the virus return within four weeks of treatment with a combination of GS-7977 and the antiviral drug ribavirin. Continue reading

The average cost to develop new drugs and other health news of the week

The average drug developed by a major pharmaceutical company costs at least $4 billion, and it can be as much as $11 billion.  Adjusting those estimates for current failure rates results in an estimate of $4 billion in research dollars spent for every drug that is approved.  However when divided (each drug company’s R&D budget by the average number of drugs approved) the dollars were far more dramatic. Continue reading

Healthcare news summary

According to new figures from Nielsen, spending on television advertising fell 23 percent to $2.4 billion from the beginning of 2007 to the end of last year. Spending in 2011 dropped 2 percent from 2010, and last year was the fourth consecutive year that such spending fell. Drug companies in the United States spent more than $3.1 billion on advertising pharmaceuticals on television in 2007, Nielsen said. Continue reading

This week in healthcare news

Type 1 diabetes — the autoimmune disease that begins in childhood and used to be called juvenile-onset diabetes — is rising, around the globe, at 3 percent to 5 percent per year. And at this point, no one can quite say why. Continue reading